The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-1 blockade in combination with bevacizumab and nab-paclitaxel for second-line treatment in cancer of unknown primary (Fudan CUP-002): A prospective, single-arm phase II study.
 
Zhiguo Luo
Research Funding - China Postdoctoral Science Foundation (I); Shanghai Anticancer Association Program
 
Xiaowei Zhang
No Relationships to Disclose
 
Ting Zhao
No Relationships to Disclose
 
Midie Xu
No Relationships to Disclose
 
Qifeng Wang
No Relationships to Disclose
 
Yanli Wang
No Relationships to Disclose
 
Liangping Zhou
No Relationships to Disclose
 
Silong Hu
No Relationships to Disclose
 
Qinghua Xu
Employment - Qinghua Xu is an employee of Canhelp Genomics Co., Ltd.
 
Xichun Hu
Honoraria - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Hengrui Pharmaceutical; Lilly; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca
 
Xin Liu
No Relationships to Disclose